Sverker Ljunghall
#127,968
Most Influential Person Now
Sverker Ljunghall's AcademicInfluence.com Rankings
Sverker Ljunghallphilosophy Degrees
Philosophy
#6080
World Rank
#9051
Historical Rank
Logic
#3273
World Rank
#4404
Historical Rank
Download Badge
Philosophy
Why Is Sverker Ljunghall Influential?
(Suggest an Edit or Addition)Sverker Ljunghall's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Excessive Dietary Intake of Vitamin A Is Associated with Reduced Bone Mineral Density and Increased Risk for Hip Fracture (1998) (386)
- Vitamin D is related to blood pressure and other cardiovascular risk factors in middle-aged men. (1995) (336)
- Risk of arrhythmias in 52 755 long-distance cross-country skiers: a cohort study. (2013) (332)
- Population-based screening for primary hyperparathyroidism with serum calcium and parathyroid hormone values in menopausal women. (1997) (302)
- Smoking, Antioxidant Vitamins, and the Risk of Hip Fracture (1999) (249)
- Hormone replacement therapy and risk of hip fracture: population based case-control study (1998) (244)
- Fracture of the distal forearm as a forecaster of subsequent hip fracture: A population-based cohort study with 24 years of follow-up (1993) (217)
- Mortality after surgery for primary hyperparathyroidism: a follow-up of 441 patients operated on from 1956 to 1979. (1987) (206)
- SURVIVAL AND RENAL FUNCTION IN UNTREATED HYPERCALCAEMIA Population-based Cohort Study with 14 Years of Follow-up (1987) (205)
- Metabolic effects of diltiazem and atenolol: results from a randomized, double-blind study with parallel groups. (1989) (205)
- Vitamin D receptor genotypes in primary hyperparathyroidism (1995) (194)
- Prevalence of hypercalcaemia in a health survey: a 14‐year follow‐up study of serum calcium values (1988) (190)
- Low plasma levels of insulin‐like growth factor 1 (IGF‐1) in male patients with idiopathic osteoporosis (1992) (189)
- A prospective study of renal stone recurrences. (1984) (163)
- External hip protectors to prevent osteoporotic hip fractures (1997) (161)
- Serum calcium: a new, independent, prospective risk factor for myocardial infarction in middle-aged men followed for 18 years. (1997) (159)
- Cigarette smoking, alcohol consumption, and risk of hip fracture in women. (2001) (155)
- Hypocalcemia and parathyroid hormone secretion in critically ill patients (2000) (154)
- Serum lipoprotein and apolipoprotein concentrations and tissue lipoprotein‐lipase activity in overt and subclinical hypothyroidism: the effect of substitution therapy (1981) (140)
- Hyperparathyroidism presenting as the first lesion in multiple endocrine neoplasia type 1. (1987) (138)
- Regulation of osteoprotegerin mRNA levels by prostaglandin E2 in human bone marrow stroma cells. (1998) (137)
- Survival after hip fracture (2005) (136)
- Increased cardiovascular mortality and normalized serum calcium in patients with mild hypercalcemia followed up for 25 years. (2001) (134)
- Bone mineral density in relation to efficacy and side effects of budesonide and prednisolone in Crohn's disease. (2005) (131)
- Gender differences in the effects of long term growth hormone (GH) treatment on bone in adults with GH deficiency. (1999) (129)
- Increased fracture rate in diabetes mellitus and females after renal transplantation. (1999) (126)
- The bone mineral density in acquired growth hormone deficiency correlates with circulating levels of insulin‐like growth factor I (1992) (126)
- Cardiovascular diseases and future risk of hip fracture in women (2007) (125)
- Relation of serum calcium concentration to metabolic risk factors for cardiovascular disease. (1988) (124)
- Oral-contraceptive use and risk of hip fracture: a case-control study (1999) (124)
- Screening for antibodies against gliadin in patients with osteoporosis (1992) (122)
- Determination of body composition--a comparison of dual-energy x-ray absorptiometry and hydrodensitometry. (1993) (122)
- Assessment of biochemical markers of bone metabolism in relation to the occurrence of fracture: A retrospective and prospective population‐based study of women (1995) (119)
- Bone Metabolism in Endurance Trained Athletes: A Comparison to Population-Based Controls Based on DXA, SXA, Quantitative Ultrasound, and Biochemical Markers (1997) (118)
- Primary Hyperparathyroidism Revisited in Menopausal Women with Serum Calcium in the Upper Normal Range at Population-based Screening 8 Years Ago (2002) (115)
- Net Fluxes Over Working Thigh of Hormones, Growth Factors and Biomarkers of Bone Metabolism During Short Lasting Dynamic Exercise (1997) (115)
- Histologic parathyroid abnormalities in an autopsy series. (1986) (114)
- Growth hormone‐dependent insulin‐like growth factor binding protein is a major determinant of bone mineral density in healthy men (1994) (114)
- The risk of hip fractures in patients with primary hyperparathyroidism: a population‐based cohort study with a follow‐up of 19 years (1993) (114)
- Insulin-like growth factor I stimulates bone turnover in osteoporosis (1992) (114)
- Diet and hip fracture risk: a case-control study. Study Group of the Multiple Risk Survey on Swedish Women for Eating Assessment. (1995) (113)
- Screening for osteopenia and osteoporosis: Selection by body composition (1996) (111)
- Socioeconomic Status, Marital Status and Hip Fracture Risk: A Population-Based Case–Control Study (2000) (110)
- Influence of parity and lactation on hip fracture risk. (2001) (110)
- Increased risk of malignant diseases after surgery for primary hyperparathyroidism. A nationwide cohort study. (1988) (109)
- Self-rated psychiatric symptoms in patients operated on because of primary hyperparathyroidism and in patients with long-standing mild hypercalcemia. (1989) (108)
- Diabetes mellitus, glucose tolerance and insulin response to glucose in patients with primary hyperparathyroidism before and after parathyroidectomy (1983) (105)
- Incidence and clinical importance of renal tubular defects in recurrent renal stone formers. (1980) (105)
- Long-term treatment with active vitamin D (alphacalcidol) in middle-aged men with impaired glucose tolerance. Effects on insulin secretion and sensitivity, glucose tolerance and blood pressure. (1989) (105)
- Tumor Necrosis Factor-α and -β Upregulate the Levels of Osteoprotegerin mRNA in Human Osteosarcoma MG-63 Cells (1998) (105)
- Normalized dyslipidaemia after parathyroidectomy in mild primary hyperparathyroidism: population‐based study over five years (2002) (103)
- Reduction of blood pressure during long-term treatment with active vitamin D (alphacalcidol) is dependent on plasma renin activity and calcium status. A double-blind, placebo-controlled study. (1989) (102)
- Risk factors for fractures of the distal forearm: A population-based case-control study (1994) (102)
- Treatment with one-alpha-hydroxycholecalciferol in middle-aged men with impaired glucose tolerance--a prospective randomized double-blind study. (2009) (101)
- Biochemical and clinical effects of the prophylactic treatment of renal calcium stones with magnesium hydroxide. (1980) (100)
- Epidemiology of renal stones in a middle-aged male population. (2009) (99)
- Case-control study on symptoms and signs of "asymptomatic" primary hyperparathyroidism. (1998) (98)
- Effects of growth hormone and insulin-like growth factor I in men with idiopathic osteoporosis. (1996) (97)
- Discordance between the degree of osteopenia and the prevalence of spontaneous vertebral fractures in Crohn's disease (2002) (97)
- Relationships Between Bone Mass Measurements and Lifetime Physical Activity in a Swedish Population (1998) (90)
- Diet, bone mass, and osteocalcin: A cross-sectional study (1995) (89)
- Vitamin D receptor genotypes in osteoporosis (1994) (89)
- Three isolation techniques for primary culture of human osteoblast-like cells: a comparison. (1999) (88)
- Decreased Estradiol Levels and Free Androgen Index and Elevated Sex Hormone-Binding Globulin Levels in Male Idiopathic Osteoporosis (1999) (88)
- Reduced serum levels of the growth hormone-dependent insulin-like growth factor binding protein and a negative bone balance at the level of individual remodeling units in idiopathic osteoporosis in men. (1997) (86)
- Incidence of Colles' fracture in Uppsala. A prospective study of a quarter-million population. (1992) (85)
- Hormone replacement therapy and risk of hip fracture: population based case-control study. The Swedish Hip Fracture Study Group. (1998) (84)
- Incidence of upper urinary tract stones. (1987) (81)
- Bone Metabolism During Exercise and Recovery: The Influence of Plasma Volume and Physical Fitness (1997) (76)
- Cerebrospinal fluid calcium, parathyroid hormone, and monoamine and purine metabolites and the blood-brain barrier function in primary hyperparathyroidism (1991) (76)
- Reduction of blood pressure by treatment with alphacalcidol. A double-blind, placebo-controlled study in subjects with impaired glucose tolerance. (2009) (76)
- Late results of operation for primary hyperparathyroidism in 441 patients. (1986) (74)
- Longitudinal studies of mild primary hyperparathyroidism (1991) (73)
- Psychiatric symptoms and cerebrospinal fluid monoamine metabolites in primary hyperparathyroidism (1988) (73)
- Two years of treatment with recombinant human growth hormone increases bone mineral density in men with idiopathic osteoporosis. (2002) (71)
- Cardiovascular risk factors in primary hyperparathyroidism: a 15‐year follow‐up of operated and unoperated cases (1991) (70)
- Bone Mineral Density in Femoral Neck is Positively Correlated to Circulating Insulin-Like Growth Factor (IGF)-I and IGF-Binding Protein (IGFBP)-3 in Swedish Men (2001) (70)
- The influence of a high dietary intake of purine-rich animal protein on urinary urate excretion and supersaturation in renal stone disease. (1983) (69)
- Polymorphism at the Sp 1 Binding Site in the Collagen Type I α 1 Gene Does Not Predict Bone Mineral Density in Postmenopausal Women in Sweden (1998) (69)
- Increased fracture risk in hypercalcemia. Bone mineral content measured in hyperparathyroidism. (1989) (69)
- Distal radius fracture is an early sign of general osteoporosis: Bone mass measurements in a population-based study (1994) (69)
- Differences in Risk Factor Patterns Between Cervical and Trochanteric Hip Fractures (1999) (67)
- Relationships Between Calcium Metabolic Indices and Blood Pressure in Patients with Essential Hypertension as Compared with a Healthy Population (1987) (66)
- Maximal isokinetic muscle strength in patients with primary hyperparathyroidism before and after parathyroid surgery (1988) (65)
- Family history of renal stones in a population study of stone-formers and health subjects. (1979) (65)
- Serum levels of parathyroid hormone are related to the mortality and severity of illness in patients in the emergency department (1997) (65)
- EFFECTS OF EXOGENOUS CATECHOLAMINES AND EXERCISE ON PLASMA MAGNESIUM CONCENTRATIONS (1985) (62)
- Patients with primary hyperparathyroidism operated on over a 24-year period: temporal trends of clinical and laboratory findings. (1987) (62)
- Six months of hormone replacement therapy does not influence muscle strength in postmenopausal women. (2002) (62)
- Blood pressure is lowered by vitamin D (alphacalcidol) during long-term treatment of patients with intermittent hypercalcaemia. A double-blind, placebo-controlled study. (2009) (61)
- Blood pressure response during long-term treatment with magnesium is dependent on magnesium status. A double-blind, placebo-controlled study in essential hypertension and in subjects with high-normal blood pressure. (1991) (61)
- Hypertension in primary hyperparathyroidism--reduction of blood pressure by long-term treatment with vitamin D (alphacalcidol). A double-blind, placebo-controlled study. (1988) (60)
- Increased bone turnover during gonadotropin-releasing hormone superagonist-induced ovulation inhibition. (1987) (60)
- Dietary habits in renal stone patients compared with healthy subjects. (1989) (60)
- Hyperparathyroidism is associated with reduced expression of a parathyroid calcium receptor mechanism defined by monoclonal antiparathyroid antibodies. (1988) (60)
- Relationship between external and cytoplasmic calcium concentrations, parathyroid hormone release and weight of parathyroid glands in human hyperparathyroidism. (1988) (60)
- Evaluation of modified multicompartment models to calculate body composition in healthy males. (1996) (59)
- Family history of renal stones in recurrent stone patients. (1985) (59)
- Defective regulation of the cytosolic Ca2+ activity in parathyroid cells from patients with hyperparathyroidism (1984) (58)
- Serum osteocalcin in rheumatoid arthritis and other inflammatory arthritides: relation between inflammatory activity and the effect of glucocorticoids and remission inducing drugs. (1986) (58)
- Long-term effects of parathyroid operation on serum calcium and parathyroid hormone values in sporadic primary hyperparathyroidism. (1992) (57)
- Effects of therapy with bendroflumethiazide in patients with recurrent renal calcium stones. (1979) (57)
- Vitamin D receptor genotypes in osteoporosis (1994) (56)
- Biochemical markers of bone metabolism during distance running in healthy, regularly exercising men and women (1996) (56)
- Psychiatric morbidity in primary hyperparathyroidism (1988) (56)
- Skeletal responsiveness to parathyroid hormone in healthy females: relationship to menopause and oestrogen replacement (1991) (56)
- Psychiatric symptomatology in patients with primary hyperparathyroidism. (1986) (55)
- Population based case-control study of sick leave in postmenopausal women before diagnosis of hyperparathyroidism (1998) (54)
- Crystal inhibition: the effects of polyanions on calcium oxalate crystal growth. (1986) (53)
- Biochemical markers of bone metabolism after short and long time ethanol withdrawal in alcoholics. (1996) (53)
- Serum phosphate inversely related to blood pressure. (1977) (52)
- Glucose and lipoprotein metabolism in primary hyperparathyroidism. Effects of parathyroidectomy. (1978) (51)
- The relation between urinary tract infections and stone composition in renal stone formers. (1989) (51)
- Increase in serum parathyroid hormone levels after prolonged physical exercise. (1988) (50)
- Bone Turnover Responses to Changed Physical Activity (2003) (49)
- Physical activity and hip fracture: a population-based case-control study (2000) (49)
- Treatment of recurrent calcium stone formation with cellulose phosphate. (1980) (48)
- Body size and hip fracture risk (2000) (48)
- Paradoxical effects of K+ and D-600 on parathyroid hormone secretion and cytoplasmic Ca2+ in normal bovine and pathological human parathyroid cells. (1985) (48)
- Metabolic cardiovascular risk factors and sodium sensitivity in hypertensive subjects. (1992) (48)
- Effects of high intake of dietary animal protein on mineral metabolism and urinary supersaturation of calcium oxalate in renal stone formers. (1984) (47)
- Parathyroid Tissue in Normocalcemic and Hypercalcemic Primary Hyperparathyroidism Recruited by Health Screening (1996) (47)
- Evaluation of bone disease in multiple myeloma: a comparison between the resorption markers urinary deoxypyridinoline/creatinine (DPD) and serum ICTP, and an evaluation of the DPD/osteocalcin and ICTP/osteocalcin ratios (1999) (46)
- PROLONGED LOW‐INTENSITY EXERCISE RAISES THE SERUM PARATHYROID HORMONE LEVELS (1986) (46)
- DXA of the Hip and Heel Ultrasound but not Densitometry of the Fingers Can Discriminate Female Hip Fracture Patients from Controls: A Comparison Between Four Different Methods (2001) (46)
- Parathyroid pathology in hyperparathyroidism secondary to chronic renal failure. (1984) (45)
- Regulation of parathyroid hormone release in primary and secondary hyperparathyroidism - studies in vivo and in vitro. (1982) (45)
- The Duration of Exercise as a Regulator of Bone Turnover (2003) (44)
- Effects of prolonged adrenaline infusion and of mental stress on plasma minerals and parathyroid hormone. (1990) (44)
- Reverse transcription-polymerase chain reaction assay demonstrates that the 9-cis retinoic acid receptor alpha is expressed in human osteoblasts. (1993) (44)
- [Vitamin D and osteoporosis]. (1995) (44)
- Clinical characteristics and surgical treatment of sporadic primary hyperparathyroidism with emphasis on chief cell hyperplasia. (1990) (44)
- Intact serum parathyroid hormone levels increase during running exercise in well-trained men (1994) (43)
- Acute effects of high-dose chemotherapy followed by bone marrow transplantation on serum markers of bone metabolism (1994) (42)
- Fracture frequency after kidney transplantation. (1994) (42)
- Parathyroid surgery in the multiple endocrine neoplasia type I syndrome: Choice of surgical procedure (1986) (42)
- Intestinal oxalate and calcium absorption in recurrent renal stone formers and healthy subjects. (1989) (42)
- Circulating levels of insulin-like growth factor-I and -II, and IGF-binding protein-3 in inflammation and after parathyroid hormone infusion. (1994) (42)
- Muscle strength correlates with total body bone mineral density in young women but not in men (2004) (41)
- Disturbance of basal and stimulated serum levels of intact parathyroid hormone in primary hyperparathyroidism. (1991) (41)
- Metabolism I (2011) (41)
- Oral isotretinoin therapy in severe acne induces transient suppression of biochemical markers of bone turnover and calcium homeostasis. (1998) (41)
- Primary hyperparathyroidism in patients with organic brain syndrome. (2009) (40)
- Tumor necrosis factor-alpha and -beta upregulate the levels of osteoprotegerin mRNA in human osteosarcoma MG-63 cells. (1998) (40)
- Stimulation of parathyroid hormone secretion by EDTA infusion--a test for the differential diagnosis of hypercalcaemia. (1986) (39)
- 1,25(OH)2D3 inhibits hormone secretion and proliferation but not functional dedifferentiation of cultured bovine parathyroid cells (1988) (38)
- Optimal discrimination of mild hyperparathyroidism with total serum calcium, ionized calcium and parathyroid hormone measurements. (1987) (38)
- Variation in the Efficacy of Hormone Replacement Therapy in the Prevention of Hip Fracture (1998) (38)
- Estrogen receptor gene polymorphism in postmenopausal primary hyperparathyroidism. (1997) (38)
- Effects of magnesium hydroxide in renal stone disease. (1982) (38)
- Cytosolic free calcium in platelets: relationships to blood pressure and indices of systemic calcium metabolism. (1988) (38)
- Interleukin (IL)-13 and IL-4 inhibit proliferation and stimulate IL-6 formation in human osteoblasts: evidence for involvement of receptor subunits IL-13R, IL-13Ralpha, and IL-4Ralpha. (2001) (38)
- Maintained bone density at advanced ages after long term treatment with low dose oestradiol implants (1993) (37)
- Histological changes in parathyroid glands in subclinical and clinical renal disease. An autopsy investigation. (1984) (37)
- Renal stone disease. Studies of epidemiology and calcium metabolism. (1977) (36)
- Regulation of Interleukin‐6 Secretion from Mononuclear Blood Cells by Extracellular Calcium (1997) (36)
- Biochemical markers of bone metabolism in patients with fracture of the distal forearm. (1993) (36)
- Inhibitory effects of 9-cis and all-trans retinoic acid on 1,25(OH)2 vitamin D3-induced bone resorption (1995) (36)
- Double Parathyroid Adenoma, a Clinically Nondistinct Entity of Primary Hyperparathyroidism (1998) (35)
- The role of the pathologist in diagnosis and surgical decision making in hyperparathyroidism (1991) (35)
- Thrombin, but not bradykinin, stimulates proliferation in isolated human osteoblasts, via a mechanism not dependent on endogenous prostaglandin formation. (1999) (35)
- Alteration in density, morphology and parathyroid hormone release of dispersed parathyroid cells from patients with hyperparathyroidism. (2009) (35)
- Incidence and natural history of renal stone disease and its relationship to calcium metabolism. (1978) (35)
- Women with climacteric symptoms: A target group for prevention of rapid bone loss and osteoporosis (1992) (34)
- Hormonal Regulation of Serum Lipoprotein(a) Levels: Contrasting Effects of Growth Hormone and Insulin-Like Growth Factor–I (1995) (34)
- Stimulus-secretion coupling of parathyroid hormone release: studies of 45Ca and 86Rb fluxes. (1985) (34)
- Prevalence of renal stones in 60-year-old men. A 10-year follow-up study of a health survey. (1987) (33)
- Hypertension in primary hyperparathyroidism in relation to histopathology. (1991) (33)
- Insulin-like growth factor I enhances the formation of type I collagen in hydrocortisone-treated human osteoblasts (1993) (32)
- Colles' fracture associated with reduced bone mineral content. Photon densitometry in 74 patients with matched controls. (1992) (32)
- Potassium and blood pressure. (1991) (32)
- IGFs: function and clinical importance 4 Growth hormone, insulin‐like growth factor I, and bone: a clinical review (1993) (32)
- Plasma potassium and phosphate concentrations--influence by adrenaline infusion, beta-blockade and physical exercise. (2009) (32)
- Magnesium metabolism in renal stone disease. (1980) (31)
- TREATMENT OF ENTERIC HYPEROXALURIA WITH CALCIUM-CONTAINING ORGANIC MARINE HYDROCOLLOID (1989) (31)
- Serum osteocalcin concentrations in patients with multiple myeloma — correlation with disease stage and survival (1992) (31)
- Renal stones and coronary heart disease. (2009) (31)
- Muscle function in patients with primary hyperparathyroidism (1989) (31)
- Primary hyperparathyroidism: Epidemiology, diagnosis and clinical picture (1991) (30)
- Secretory disturbance in hyperplastic parathyroid nodules of uremic hyperparathyroidism: Implication for parathyroid autotransplantation (1988) (30)
- A double‐blind comparison of the effects of haloperidol and cis(Z)‐clopenthixol in senile dementia (1981) (28)
- Inhibitory activity of human urine on calcium oxalate crystal growth: effects of sodium urate and uric acid. (1982) (28)
- Calcium and magnesium metabolism during long-term treatment with thiazides. (1981) (28)
- Dual X-ray absorptiometry of hip, heel ultrasound, and densitometry of fingers can discriminate male patients with hip fracture from control subjects: a comparison of four different methods. (2002) (28)
- Prevention of renal stones by a high fluid intake? (1988) (28)
- Hormonal regulation of serum lipoprotein(a) levels. Contrasting effects of growth hormone and insulin-like growth factor-I. (1994) (27)
- Parathyroid surgery in chronic renal insufficiency. Subtotal parathyroidectomy versus total parathyroidectomy with autotransplantation to the forearm. (1982) (27)
- Bradykinin induces formation of inositol phosphates and causes an increase in cytoplasmic Ca2+ in the osteoblastic cell line MC3T3‐E1 (1991) (27)
- Magnesium metabolism in healthy subjects. (1979) (27)
- Whole-Body Bone Mineral Measurements in 15-Year-Old Swedish Adolescents (1999) (26)
- Change in levels of the carboxyterminal propeptide of type I procollagen, the carboxyterminal cross‐linked telopeptide of type I collagen and osteocalcin in response to exercise in well‐trained men and women (1994) (25)
- Serum calcium and the ECG in patients with primary hyperparathyroidism. (1994) (25)
- Body size and hip fracture risk. Swedish Hip Fracture Study Group. (2000) (25)
- Surgery for sporadic primary hyperparathyroidism in the elderly (1994) (25)
- Metabolic cardiovascular risk factors and the renin-aldosterone system in essential hypertension. (1992) (24)
- Calcium, phosphate and albumin in serum. A population study with special reference to renal stone formers and the prevalence of hyperparathyroidism in middle-aged men. (2009) (24)
- Cardiovascular diseases and future risk of hip fracture in women. Osteoporos Int (2007) (24)
- Thrombin increases cytoplasmic Ca2+ and stimulates formation of prostaglandin E2 in the osteoblastic cell line MC3T3-El. (1991) (24)
- Optimal screening for patients with hyperparathyroidism with use of serum calcium observations. A decision-theoretical analysis. (1983) (23)
- Pre‐operative evaluation of risk factors for complications in patients with primary hyperparathyroidism (1995) (23)
- Insulin-like Growth Factor I Does Not Stimulate Bone Resorption in Cultured Neonatal Mouse Calvarial Bones (1996) (23)
- Urinary excretion of urate in renal calcium stone disease and in renal tubular acidification disturbances. (1982) (22)
- Regional and systemic effects of short‐term intense muscular work on plasma concentration and content of total and ionized calcium (1985) (21)
- SCREENING FOR MULTIPLE ENDOCRINE NEOPLASIA SYNDROME (TYPE 1) IN PATIENTS WITH PRIMARY HYPERPARATHYROIDISM (1984) (21)
- Almost all institutionalized women are osteoporotic, when measured by heel and finger ultrasound (2001) (20)
- Circulating ionized calcium and parathyroid hormone levels following coronary artery by-pass surgery. (1999) (20)
- On the relationships between mineral metabolism, obesity and fat distribution. (1995) (20)
- Intestinal absorption of oxalate and calcium in patients with jejunoileal bypass. (1989) (20)
- Suppression of serum parathyroid hormone levels by intravenous alphacalcidol in uremic patients on maintenance hemodialysis. A pilot study. (1988) (19)
- Binding of glycosaminoglycan inhibitors to calcium oxalate crystals in relation to ionic strength. (1989) (19)
- Partial lipodystrophy and chronic hypocomplementemic glomerulonephritis. (2009) (19)
- Platelet and plasma catecholamines in relation to plasma minerals and parathyroid hormone following acute myocardial infarction. (1990) (19)
- Physical activity and hip fracture: a population-based case-control study. Swedish Hip Fracture Study Group. (2000) (19)
- IMPAIRED SECRETION OF PARATHYROID HORMONE IN PATIENTS WITH RHEUMATOID ARTHRITIS: RELATIONSHIP TO INFLAMMATORY ACTIVITY (1990) (19)
- Cytogenetical investigations in patients with primary hyperparathyroidism and multiple endocrine neoplasia type 1. (2008) (18)
- Adult human osteoblast-like cells do not express insulin-like growth factor-I. (1994) (18)
- Binding of glycosaminoglycans to sodium urate and uric acid crystals. (1986) (18)
- Synthetic human calcitonin in postmenopausal osteoporosis: A placebo-controlled, double-blind study (2007) (18)
- Ambulatory diagnostic evaluation of 389 recurrent renal stone formers (1983) (18)
- Clodronate treatment in patients with malignancy-associated hypercalcemia. (2009) (18)
- Role of protein kinase C in bradykinin-induced prostaglandin formation in osteoblasts. (1993) (18)
- Treatment with active vitamin D (alphacalcidol) in patients with mild primary hyperparathyroidism. (1989) (18)
- Prophylactic treatment of renal calcium stones. Experiences with dietary advice, cellulose, phosphate and thiazides. (1980) (18)
- Clinical effects of parathyroid surgery in normocalcaemic patients with recurrent renal stones. (1980) (17)
- Interleukin-13 inhibits cell proliferation and stimulates interleukin-6 formation in isolated human osteoblasts. (1998) (17)
- Neuromuscular involvement in primary hyperparathyroidism (2004) (17)
- Use of low potency estrogens does not reduce the risk of hip fracture. (2002) (17)
- Histological and clinical features of non-familial primary parathyroid hyperplasia. (1992) (17)
- Comparative effects of calcitonin and clodronate in hypercalcaemia. (1987) (17)
- PDGF-BB, but not PDGF-AA, stimulates calcium mobilization, activation of calcium channels and cell proliferation in cultured rat mesangial cells. (1993) (17)
- Normalizing effect of Ca2+ ionophore on cytoplasmic Ca2+ and parathyroid hormone release of dispersed parathyroid cells from patients with hyperparathyroidism (1986) (16)
- Fasting insulin, calcium metabolism and the electrocardiogram in hypertensive subjects (1992) (16)
- Relation between changes in clinical and histopathological features of primary hyperparathyroidism (1986) (16)
- A stimulation test with calcitonin for differential diagnosis of hypercalcaemia. (1984) (16)
- Serum osteocalcin levels in normal subjects and patients with primary hyperparathyroidism. (2009) (16)
- Urate metabolism in primary hyperparathyroidism. (1982) (16)
- Critical care hypercalcemia--a hyperparathyroid state. (2009) (16)
- Heel ultrasound in women after long-term ERT compared with bone densities in the forearm, spine and hip (1995) (16)
- Effect of prefracture versus postfracture dietary assessment on hip fracture risk estimates. (1996) (15)
- Serum electrolytes and parathyroid hormone concentrations in acute myocardial infarction. (2009) (15)
- Pronounced elevation in circulating calcitonin in critical care patients is related to the severity of illness and survival (2006) (15)
- Mortality of untreated primary hyperparathyroidism--a nontraditional indication for parathyroid surgery? (1995) (15)
- Indices of mineral metabolism in relation to blood pressure in a sample of a healthy population. (2009) (15)
- Plasma ionized calcium and cardiovascular risk factors in mild primary hyperparathyroidism: effects of long‐term treatment with active vitamin D (Alphacalcidol) (1992) (15)
- Allopurinol treatment of renal calcium stone disease. (1985) (15)
- Polymorphisms in the renin-angiotensin system and endothelium-dependent vasodilation in normotensive subjects. (2001) (14)
- Use of clodronate and calcitonin in hypercalcemia due to malignancy. (1989) (14)
- Hypercalcemia in pulmonary tuberculosis. (1990) (14)
- Changes in calcium metabolic indices during long-term treatment of patients with essential hypertension. (1988) (14)
- CIMETIDINE IN PRIMARY HYPERPARATHYROIDISM (1980) (14)
- Cytologic diagnosis of a medullary carcinoma of the thyroid by Sevier-Munger silver staining and calcitonin immunocytochemistry. (1987) (13)
- The positive effect of dietary vitamin D intake on bone mineral density in men is modulated by the polyadenosine repeat polymorphism of the vitamin D receptor. (2006) (13)
- Acute effects of ethanol intake on the serum concentrations of parathyroid hormone, calcium and phosphate. (2009) (13)
- Studies on two new vitamin D analogs, EB 1089 and KH 1060: effects on bone resorption and osteoclast recruitment in vitro. (1995) (13)
- Magnesium metabolism in renal stone formers. Effects of therapy with magnesium hydroxide. (1980) (13)
- Crystal Inhibition:Binding of Heparin and Chondroitin Sulphate to Calcium Oxalate, Sodium Urate and Uric Acid Crystals (1985) (13)
- Incidence, type and severity of psychic symptoms in patients with sporadic primary hyperparathyroidism. (1992) (13)
- Prophylactic Treatment with Magnesium Hydroxide in Renal Stone Disease (1981) (13)
- A case of Albright's syndrome treated with calcitonin. (1979) (13)
- A New fluorometric assay for determination of osteoblastic proliferation: Effects of glucocorticoids and insulin-like growth factor-I (2009) (12)
- DYNAMIC TESTS OF PARATHYROID FUNCTION FOR DIAGNOSIS OF PRIMARY HYPERPARATHYROIDISM IN MALIGNANCY (1987) (12)
- Cellular physiology and pathophysiology of the parathyroid glands (1991) (12)
- Enzymatic determination of urinary chondroitin sulphate: applications in renal stone disease and acromegaly (1986) (12)
- Serum electrolytes and parathyroid hormone in patients in a coronary care unit (1989) (12)
- Ga3+ inhibits parathyroid hormone release without interacting with the Ca2+ receptor of the parathyroid cell. (1992) (12)
- Urinary excretion of cyclic AMP in hyperparathyroidism. (1978) (12)
- The Inhibition of Calcium Oxalate Crystal Growth by Chondroitin Sulphates, Heparin, Pentosan Polysulphate and Tamm-Horsfall Glycoprotein (1985) (11)
- The cyclic-AMP antagonist adenosine-3',5'-cyclic monophosphosphorothioate, RP-isomer inhibits parathyroid hormone induced bone resorption, in vitro. (1993) (11)
- Effects of beta-adrenergic blockade on serum parathyroid hormone in normal subjects and patients with primary hyperparathyroidism. (2009) (11)
- Effects on serum parathyroid hormone of intravenous treatment with alphacalcidol in patients on chronic hemodialysis. (1990) (11)
- Age-Dependent Effect of Oral Glucocorticoids on Markers of Bone Resorption in Patients with Acute Asthma (1998) (11)
- Epidemiological aspects of renal stone disease in Scandinavia. (1980) (11)
- Surgical findings and results of subtotal and total parathyroidectomy in hypercalcemic patients with uremic hyperparathyroidism. (1989) (11)
- The calcitonin gene-related peptide (CGRP) response to intravenous calcium is related to blood pressure. (1988) (11)
- Urinary pyrophosphate excretion in renal stone formers with normal and impaired renal acidification (1983) (11)
- Incidence of Renal Stones in Western Countries (1985) (11)
- Myositis ossificans progressiva. Clinical and metabolical observations in a case treated with a diphosphonate (EHDP) and surgical removal of ectopic bone. (1979) (11)
- Effects of parathyroid hormone on cyclic AMP-formation and cytoplasmic free Ca2+ in the osteosarcoma cell line UMR 106-01 (1992) (10)
- A high dietary calcium intake is needed for a positive effect on bone density in Swedish postmenopausal women (2005) (10)
- Vasoactive intestinal polypeptide stimulates parathyroid hormone release by interaction with cyclic adenosine monophosphate production of bovine parathyroid cells. (1991) (10)
- Cytoplasmic calcium regulation and the electrocardiogram in patients with primary hyperparathyroidism. (1994) (10)
- Calcium metabolism and sodium sensitivity in hypertensive subjects. (1993) (10)
- Ultrasound scanning for preoperative location of parathyroid tumours. (1984) (10)
- Bromocriptine therapy in eleven patients with acromegaly. (1978) (10)
- Clinical studies of calcium metabolism in essential hypertension. (1987) (10)
- Short-term effects of pamidronate on biochemical markers of bone metabolism in osteoporosis--a placebo-controlled dose-finding study. (1991) (10)
- Serum osteocalcin and fracture susceptibility in elderly women (1993) (10)
- Dietary History and Dietary Records in Renal Stone Patients and Controls (1985) (10)
- Influences of different antihypertensive treatments on indices of systemic mineral metabolism. (1994) (10)
- Parathyroid hormone release in vitro in hyperparathyroidism associated with multiple endocrine neoplasia type 1. (1987) (10)
- The influence of body composition on left ventricular mass and other echocardiographic and Doppler measurements in 70-year-old males. (1995) (10)
- Clinical and Laboratory Findings in Patients with Medullary Sponge Kidney (1981) (10)
- Treatment of primary hyperparathyroidism with cyclofenil--a synthetic stilbestrol derivative with minimal feminizing effects. (1984) (9)
- Effects of propranolol and verapamil on plasma ionized calcium and parathyroid hormone in short-term intense isokinetic leg exercise. (1988) (9)
- Relationship between abnormal regulation of cytoplasmic calcium and elevated blood pressure in patients with primary hyperparathyroidism. (1994) (9)
- Ultrasonic Appearance of Adenomatous and Hyperplastic Parathyroid Glands (1984) (9)
- Hormone replacement therapy and hip fracture risk : population based case-control study (1998) (9)
- Hypertension, primary hyperparathyroidism and the parathyroid hypertensive factor. (1993) (9)
- Normalization of hypercalcaemia of primary hyperparathyroidism by treatment with methallenestril, a synthetic oestrogen with low oestrogenicity. (1983) (9)
- Cellular retinoic acid-binding protein type II is expressed in adult human osteoblasts and in adult liver. (1992) (9)
- A pilot study of metabolic effects of intravenously given alpha-calcidol in patients with chronic renal failure. (1988) (9)
- Evaluation of parathyroid function in patients with hypergastrinaemia and pernicious anaemia. (1982) (9)
- A Pilot Study of Metabolic Effects of Intravenously Given Alpha-Calcidol In Patients With Chronicc Renal Failure. (1988) (9)
- Parathyroid hormone and blood pressure--is there a relationship? (1995) (8)
- Regional variations in the incidence of urinary stones (1978) (8)
- Long-Term Treatment with Bendroflumethiazide for Prevention of Renal Stones. Clinical Experiences (1981) (8)
- Dual effects of a new hypocalcemic agent, WR-2721, on cytoplasmic Ca2+ and parathyroid hormone release of dispersed parathyroid cells from patients with hyperparathyroidism. (1986) (8)
- Phosphate metabolism in renal stone formers. (II): Relation to renal tubular functions and calcium metabolism. (1981) (8)
- Glycosaminoglycans and renal stone disease: clinical effects of pentosan polysulphate (Elmiron) (1987) (8)
- Reduction of serum parathyroid hormone levels during sympathetic stimulation in man (1987) (8)
- Interactions between indices of calcium metabolism and blood pressure during calcium infusion in humans. (1989) (8)
- Insulin-induced hypoglycaemia stimulates secretion of parathyroid hormone. (2009) (8)
- Effects of 1,25- and 24,25-dihydroxycholecalciferol on parathyroid hormone release from human parathyroid cells in vitro. (1984) (8)
- Journal of Internal Medicine and the new century (2001) (8)
- Magnesium homeostasis in mild-to-moderate primary hyperparathyroidism. (1980) (8)
- Calcium metabolism in renal stone disease. (1980) (8)
- Serum urate and renal function in different forms of hypercalcemia. (2009) (8)
- Growth hormone secretion and sensitivity in men with idiopathic osteoporosis (2001) (8)
- Parathyroid hormone is able to enhance cyclic adenosine monophosphate formation without causing an increase in cytoplasmic Ca2+ in osteoblasts. (1993) (7)
- HLA and kidney stone disease. (1978) (7)
- Ultrasonic localization and cytologic identification of parathyroid tumors (1984) (7)
- Competitive PCR demonstrates that 9-cis retinoic acid induces cellular retinoic acid-binding protein-II more efficiently than all-trans retinoic acid in human osteosarcoma cells. (1994) (7)
- Indices of mineral metabolism in subjects with an impaired glucose tolerance. (2009) (7)
- Effects of bendroflumethiazide on urate metabolism during treatment of patients with renal stones. (1982) (7)
- CORRELATIONS BETWEEN ISOMETRIC QUADRICEPS MUSCLE STRENGTH AND BONE MINERAL DENSITY (1999) (7)
- Dynamics of parathyroid hormone release and serum calcium regulation after surgery for primary hyperparathyroidism (1992) (7)
- Monoclonal antiparathyroid antibodies revealing defect expression of a calcium receptor mechanism in hyperparathyroidism (1988) (7)
- Renal Stone Formation in Primary Hyperparathyroidism — Role of Tubular Dysfunction (1981) (7)
- The Role of Pathology in Diagnosis and Surgical Decision-Making1 (1986) (6)
- Treatment with cimetidine in patients with primary hyperparathyroidism. (1982) (6)
- Uricemia and urinary acidification in renal calcium stone disease. (1983) (6)
- Calcium intake among women aged 40-76 in Sweden. Study Group MRS SWEA. Multiple Risk Survey on Swedish Women for Eating Assessment. (1996) (6)
- Effects of secretin on parathyroid hormone and calcium in normal subjects, patients with hyperparathyroidism and patients with gastrinoma. (2009) (6)
- Carboxyterminal telopeptide of type I collagen, ICTP, as a marker of matrix degradation in neonatal mouse calvarial bones,in vitro (1992) (6)
- Urinary composition and supersaturation on a high protein diet. (1984) (6)
- Prediction of Stone Recurrence (1981) (6)
- Hyperoxaluria or hypercalciuria in nephrolithiasis: the importance of renal tubular functions (1990) (6)
- The Effect of Dietary Animal Protein on Calcium Metabolism (1982) (5)
- Parathyroid autotransplantation. An investigation of parathyroid autograft function. (1983) (5)
- Magnesium Metabolism in Renal Stone Formers (1981) (5)
- Delayed hypersensitivity in primary and secondary hyperparathyroidism. Treatment with active vitamin D. (2009) (5)
- 120 The serum level of diltiazem determines the blood pressure response and insulin sensitivity during antihypertensive treatment (1993) (5)
- The Clinical Importance of Renal Tubular Acidosis in Recurrent Renal Stone Formers (1981) (5)
- Growth hormone and insulin-like growth factor-I do not activate identical genes in normal human osteoblasts. (1996) (5)
- Calcium metabolic indices, vascular retinopathy, and plasma renin activity in essential hypertension. (1990) (5)
- Serum chloride in the differential diagnosis of hypercalcemia. (2009) (5)
- Technical Aspects of Magnetic Resonance Imaging in Parathyroid Gland Lesions (1986) (5)
- Glucose metabolism in renal stone formers. (1978) (5)
- Development of abnormal parathyroid cell function during monolayer culture and its relation to cellular hypertrophy and proliferation. (2009) (5)
- [Gluteal infection in weight lifters after injection of anabolic steroids]. (1985) (4)
- Interleukin-1 beta induces cyclic AMP formation in isolated human osteoblasts: a signalling mechanism that is not related to enhanced prostaglandin formation. (1994) (4)
- Inflammatory bowel disease and osteoporosis. (1999) (4)
- Environmental factors in the development of urolithiasis. (1984) (4)
- Stone Analysis and Urinary Tract Infection in Renal Stone Patients (1985) (4)
- Urinary Citrate Excretion and Acidification Defects in Renal Calcium Stone Formers (1981) (4)
- Calcium metabolism and arterial blood pressure in a healthy population sample and in hypertensive men. (1986) (4)
- Journal of Internal Medicine– a journal for the internist (1996) (4)
- The Effects of Animal Protein on the Urinary Excretion of Citrate and Acid Base Status (1982) (4)
- CHAPTER 21 – Clinical Presentation of Primary Hyperparathyroidism: Europe (2001) (4)
- Serum concentrations of parathyroid hormone in euparathyroid subjects during cimetidine treatment. (1980) (4)
- An association between mineral metabolism and the renin-aldosterone system in human hypertension. (1989) (4)
- [Management of asymptomatic primary hyperparathyroidism. New North American guidelines discussed from a Swedish perspective]. (2003) (4)
- Effects of infusion of parathyroid hormone and primary hyperparathyroidism on formation and breakdown of type I collagen (1994) (4)
- Endocrine interactions of insulin‐like growth factor I on bone (1994) (4)
- Serum levels of 1,25-(OH)2-vitamin D are not altered by long-term supplementation with alphacalcidol (1-OH-vitamin D3). A double-blind, placebo-controlled study. (2009) (4)
- Hyperoxaluria or hypercalciuria in nephrolithiasis: the importance of renal tubular functions (1990) (4)
- Experiences with Long-Term Use of Sodium Cellulose Phosphate for Prevention of Renal Calcium Stones (1981) (4)
- Reduction in serum alkaline phosphatase levels by treatment with active vitamin D (alphacalcidol) in primary and secondary hyperparathyroidism and in euparathyroid individuals. (1991) (4)
- Letter: Renal stones and coronary heart disease. (1975) (4)
- An intensive course in clinical skills: The Uppsala model (1996) (4)
- No major metabolic alterations accompany the hypotensive effect of active vitamin D. (1991) (4)
- Clinical studies on phosphate handling in hypercalcaemia. (2009) (3)
- Controversies in the treatment of hyperparathyroidism. (1979) (3)
- Serum and urinary urate in stone formers. (1980) (3)
- Urate Metabolism and Urinary Acidification (1981) (3)
- Discussion section IV (1991) (3)
- [Continuous remodeling of the skeleton. Growth factors and cytokines direct the activity]. (1995) (3)
- Clinical and experimental advances in sporadic primary hyperparathyroidism. (1990) (3)
- Long-term Treatment with Bendroflumethiazide for Prevention of Stones. Metabolic Effects (1981) (3)
- Serum myoglobin concentrations are decreased by beta-adrenergic stimulation (2004) (3)
- Bone resorption induced by A23187 is abolished by indomethacin: implications for second messenger utilised by parathyroid hormone. (1998) (3)
- Phosphate metabolism in renal stone formers. (I): Indices of phosphate handling in calcium stone patients and healthy subjects. (1981) (3)
- Journal of Internal Medicine and the new century (2000) (3)
- New Drugs to Prevent Recurrence of Renal Stone Disease (1991) (3)
- Blood pressure reaction during the intraoperative and early postoperative periods in patients with primary hyperparathyroidism. (2009) (3)
- On the diversity of insulin secretion and sensitivity in subjects with impaired glucose tolerance. (2009) (2)
- Dietary animal protein and urinary supersaturation in renal stone disease. (1983) (2)
- Regulation of bone cells by 1,25(OH)2D3. (1995) (2)
- What's hip in diet and osteoporosis? (1997) (2)
- Tubular proteinuria in renal calcium stone formers. (1985) (2)
- The interaction of urinary inhibitors with crystals (1982) (2)
- Phosphate Treatment of Calcium Urolithiasis (1985) (2)
- Clinical Characteristics of the Calcium Stone Disease in Hyperuricosuria (1981) (2)
- Parathyroid hormone and osteocalcin levels in plasma and ultrafiltrate during hemofiltration. (1993) (2)
- Prophylactic treatment of renal stone disease with magnesium hydroxide during five years (1982) (2)
- Improved differential diagnosis of hypercalcemia by hypocalcemic stimulation of parathyroid hormone secretion (1988) (2)
- Combined Enzymatic Degradation with Chondroitinases and Alcian Blue Precipitation in Determination of Urinary Chondroitin Sulphates (1985) (2)
- 89. Metabolic cardiovascular risk factors and sodium sensitivity in hypertensive subjects (1991) (2)
- Experience with the Short Ammonium Chloride Test (1981) (2)
- Renal handling of urate in patients with calcium stone disease. (1982) (2)
- Gel Filtration of Concentrated Urine: the Relation Between Calcium Oxalate Crystal Growth Inhibition and Glycosaminoglycan Chromatograms (1985) (2)
- The mechanism of glycosaminoglycan inhibition of calcium oxalate crystal growth (1980) (2)
- Electrocardiographic changes during antihypertensive treatment with diltiazem in relation to the achieved serum levels of the drug. (1994) (2)
- [Osteoporosis--what can and should be done in Sweden 1996? Swedish Osteoporosis Society]. (1996) (2)
- Treatment with clodronate in patients with hypercalcemia secondary to malignancy. (1987) (2)
- Parathyroid function in relation to intestinal function and renal calcium reabsorption in patients with nephrolithiasis. (1992) (1)
- Medical and radiologic evaluation and operative treatment of primary hyperparathyroidism. (1993) (1)
- Effects of Phosphate Treatment in Calcium Urolithiasis (1984) (1)
- Clinical characteristics of renal stone disease in relation to urinary oxalate excretion (1988) (1)
- Urate Metabolism in Calcium Stone Disease (1981) (1)
- Biochemical indices of calcium homeostasis immediately after kidney transplantation (1997) (1)
- Maintained Bone Density at Advanced Ages After Long-Term Treatment With Low-Dose Estradiol Implants (1993) (1)
- Effects of clofibrate on glucose tolerance, serum insulin, serum lipoproteins and plasma fibrinogen (1977) (1)
- The importance of residual calculi on recurrence in patients with infection stones (1988) (1)
- Heredity, Serum Phosphate and Urinary Calcium in Calcium Urolithiasis (1985) (1)
- Oxalate and calcium absorption tests in patients after jejunoileal anastomosis and in idiopathic renal stone formers in comparison with healthy subjects (1987) (1)
- Primary hyperparathyroidism. Aspects on pathophysiology, symptoms, and treatment. (1991) (1)
- The effects of dietary protein on urate metabolism (1982) (1)
- Use of Novel Bone Biopsy System to Study Molecular Effectst of Growth Hormone in Human Bone‐ A Pilot Study (1999) (1)
- The Possibility of a Specific Calcium Sensor/Receptor Function of Proximal Renal Tubular Cells (1989) (1)
- Cloning of a novel retinoic acid‐inducible mRNA from human osteoblast‐like cells (1997) (1)
- Values of intact serum parathyroid hormone in different stages of renal insufficiency. (1991) (1)
- Vertebral fractures : a frequent extra-intestinal manifestation in Crohn's disease (2001) (1)
- Differential diagnosis of hypercalcaemia and indications for treatment. (1983) (1)
- Subject Index, Vol. 6 (Suppl. 1), 1986 (1986) (0)
- Effeds 01 Phosphate Treatment in Caldum Urolithiasis (1984) (0)
- Intestinal Absorption of Oxalate and Calcium (1989) (0)
- Combined pharmaceutical preparation comprising parathyroid hormone and one inhibitor of bone resorption. (1998) (0)
- The pharmaceutical combination product of parathyroid hormone and a bone resorption inhibitor (1998) (0)
- [Personal instruction in a new model of education]. (1995) (0)
- Biochemical Markers of Bone Metabolism in Patients With Fracture (2006) (0)
- Cytosolic calcium as regulator of parathyroid hormone secretion in cells in normal and hyperparathyroid glands (1985) (0)
- Growth hormone secretion and IGF-I/IGFBP-3 determinants of bone turnover in men with idiopathic osteoporosis (1998) (0)
- 92087769 Synthetic human calcitonin in postmenopausal osteoporosis: A placebo- controlled, double-blind study (1992) (0)
- ORIGINAL ARTICLES CORRELATIONS BETWEEN ISOMETRIC QUADRICEPS MUSCLE STRENGTH AND BONE MINERAL DENSITY (1999) (0)
- [Giving up smoking by 50-year-old males]. (1978) (0)
- [Primary hyperparathyroidism--a frequently overlooked cause of psychological symptoms]. (1991) (0)
- Contents, Vol. 33, 1978 (1978) (0)
- [Hypercalcemia and skeletal engagement in malignancy--development and therapeutic possibilities]. (1989) (0)
- Contents, Vol. 55, 1990 (1990) (0)
- [Experiences in a special kidney calculi admitting department]. (1978) (0)
- Case-control study on symptoms and signs of [ldquo ]asymptomatic[rdquo ] primary hyperparathyroidism (1998) (0)
- [Rhyme and reason in osteoporosis treatment]. (1996) (0)
- Calcium metabolism in critical illness.In: The endocrine response to critical illness. (1998) (0)
- Primary hyperparathyroidism in patients with organic brain syndrome (1987) (0)
- Impaired bone mineralization in mink pups following chronic PCB exposure of the dam (1996) (0)
- [Asymptomatic primary hyperparathyroidism: surgery or follow-up?]. (1991) (0)
- Pharmaceutical co-formulation of parathyroid hormone and a bone resorption inhibitor (1998) (0)
- Renal Tubular Handling of Urate in Calcium Stone Formers with Hyperuricosuria or Renal Acidification Defects (1981) (0)
- Net Release and Uptake of Growth Factors and Biomarkers of Bone Metabolism in Thigh during Short Lasting Dynamic Exercise (1994) (0)
- Evaluation of renal concentrating ability with DDAVP and pitressin. (1983) (0)
- Increased risk for hip fracture and low bone mineral density with high dietary intake of vitamin A (2006) (0)
- Effects of IGF-I and GH treatment on bone metabolism and bone density, with special reference to GH deficiency (1995) (0)
- Contents, Vol. 38, 1983 (1983) (0)
- Kidney stone disease. Experiences from Uppsala, Sweden. (1980) (0)
- Lipid-lowering effects of two synthetic oestrogen derivatives with weak genital oestrogen properties. (1985) (0)
- Surgery for primary hyperparathyroidism-long term effects on serum calcium and intact parathyroid hormone, values (1992) (0)
- Indications for surgery still exist in asymptomatic primary hyperparathyroidism (1992) (0)
- The Influence of Dietary Factors on Hip Fracture Risk and Bone Mass (1995) (0)
- [Drugs exist--but changing of life style can be sufficient in the prevention of osteoporosis]. (1990) (0)
- [Bone mass, osteoporosis and fractures--what do heredity and environment mean?]. (1989) (0)
- Evaluation by integrated thermography of the beneficial effect of cyclofenil in severe subcutaneous arterial insufficiency. (1985) (0)
- Subject Index, Vol. 55, 1990 (1990) (0)
- [How should osteoporosis be treated?]. (1993) (0)
- 38 Interrelationships between changes in calcium metabolic indices and blood pressure during calcium infusion in humans (1988) (0)
- On the interplay beween insulin secretion and sensitivity as determinants of glucose tolerance (1994) (0)
- [How much calcium do we need in our diet?]. (1991) (0)
- 90. Serum phosphate and blood pressure (1991) (0)
- [Etiology of hypercalciuria in recurrent kidney calculi]. (1978) (0)
- 93154735 Maintained bone density at advanced ages after long term treatment with low dose oestradiol implants (1994) (0)
- Smoking, Antioxidant Vitamins and the Risk of Hip Fracture (1999) (0)
- [Kidney function in kidney calculi patients]. (1978) (0)
- [Preventive therapy in patients with recurrent kidney calculi]. (1978) (0)
- [Osteoporosis can be diagnosed, prevented and treated]. (1991) (0)
- Urinary acidification and pyrophosphate excretion in nephrolithiasis (1982) (0)
- [Negative effects of steroids on bone mass. Guidelines for prevention of osteoporosis]. (1994) (0)
- Renal handling of urate in renal stone patients during treatment with thiazides (1982) (0)
- [How to differentiate between health and disease in diagnosing the elderly?]. (1992) (0)
- Contents, Vol. 48, 1988 (1975) (0)
- GLUCOSE TOLERANCE IN IDIOPATHIC CALCIUM-STONE FORMATION (1975) (0)
- Urinary Tract Infections in Renal Stone Disease (1984) (0)
- [Hypertension as a systemic metabolic disease]. (1989) (0)
- PTH secretory dynamics and Ca2+ homeostatics after surgery for primary hyperparathyroidism (1992) (0)
- [New findings on osteoporosis]. (1985) (0)
- [Hypertensive patients have varying susceptibilities to salt]. (1992) (0)
- Bone matrix metabolism in lleo-cecal Crohn's disease. Does disease activity matter? (2001) (0)
- 123 The relationship between abnormal regulation of cytoplasmic calcium and elevated blood pressure in patients with primary hyperparathyroidism (1993) (0)
- Bone biomarkers during long term running (1996) (0)
- [Osteoporosis may be prevented]. (1995) (0)
- 91158366 Skeletal responsiveness to parathyroid hormone in healthy females: Relationship to menopause and oestrogen replacement (1991) (0)
- The effects of methenamine-hippurate upon urinary risk factors for renal stone formation. (1985) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Sverker Ljunghall?
Sverker Ljunghall is affiliated with the following schools:
